RecruitingNCT05460143

Optical Neuroimaging and Cognition

Studying NON RARE IN EUROPE: Alzheimer disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Cambridge
Principal Investigator
Gemma Bale, PhD
University of Cambridge
Intervention
Near-infrared Spectroscopy scan(other)
Enrollment
200 target
Eligibility
18 years · All sexes
Timeline
2023 – 2025

Study locations (1)

Collaborators

Cambridgeshire and Peterborough NHS Foundation Trust · The Gianna Angelopoulos Programme for Science, Technology and Innovation · The Newton Trust · Alzheimer's Research UK

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05460143 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Alzheimer disease

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Alzheimer disease →

← Back to all trials